SCHEMBL387735

SCHEMBL387735

[CH2]COC1C2CC3CC(C2)CC1C3

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.33
FDFT1 P37268 1/20 0.32
HSD11B1 P28845 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL92309 0.74 FDFT1 (0.35) CYP2C9FDFT1HSD11B1
SCHEMBL855901 0.74 CYP2C9 (0.33) CYP2C9FDFT1HSD11B1
SCHEMBL4806257 0.70 FDFT1 (0.31) FDFT1
SCHEMBL29226312 0.70 FDFT1 (0.40) CYP2C9FDFT1HSD11B1
SCHEMBL13697603 0.70 FDFT1 (0.33) CYP2C9FDFT1
SCHEMBL16566372 0.70 FDFT1 (0.36) CYP2C9FDFT1
SCHEMBL19798414 0.70 FDFT1 (0.40) CYP2C9FDFT1HSD11B1
SCHEMBL19798411 0.69 FDFT1 (0.39) CYP2C9FDFT1HSD11B1
SCHEMBL251015 0.69 CYP2C9 (0.38) CYP2C9HSD11B1
SCHEMBL19798422 0.69 FDFT1 (0.39) FDFT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859187-B2 Method of forming resist pattern and negative resist composition TOKYO OHKA KOGYO CO., LTD. (JP) 2014-10-14 US disclosed
EP-1895576-B1 PATTERN FORMING METHOD TOKYO OHKA KOGYO CO LTD (JP) 2014-07-23 EP disclosed
US-8349543-B2 Pattern-forming method, metal oxide film-forming material and method for using the metal oxide film-forming material TOKYO OHKA KOGYO CO. LTD. (JP) 2013-01-08 US disclosed
US-8124312-B2 Method for forming pattern, and material for forming coating film TOKYO OHKA KOGYO CO., LTD. (JP) 2012-02-28 US disclosed
US-8101013-B2 Film-forming material and method of forming pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2012-01-24 US disclosed
US-8043795-B2 Method of forming resist pattern TOKYO OHIKA KOGYO CO., LTD. (JP) 2011-10-25 US disclosed
US-8025923-B2 Method for manufacturing a structure TOKYO OHKA KOGYO CO., LTD. (JP) 2011-09-27 US disclosed
US-7932013-B2 Pattern coating material and pattern forming method TOKYO OHKA KOGYO CO., LTD. (JP) 2011-04-26 US disclosed
US-20100234316-A1 Nucleoside Aryl Phosphoramidates for the Treatment of RNA-Dependent RNA Viral Infection MSD ITALIA S.R.L. (IT) 2010-09-16 US disclosed
US-20100062379-A1 METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2010-03-11 US disclosed
US-7638258-B2 Positive resist composition and method for resist pattern formation TOKYO OHKA KOGYO CO., LTD. (JP) 2009-12-29 US disclosed
US-20090286936-A1 COMPOSITION FOR FORMATION OF MOLD TOKYO OHKA KOGYO CO., LTD. (JP) 2009-11-19 US disclosed
US-20090269706-A1 METHOD FOR FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2009-10-29 US disclosed
US-20090191478-A1 METHOD OF FORMING RESIST PATTERN AND NEGATIVE RESIST COMPOSITION TOKYO OHKA KOGYO CO., LTD (JP) 2009-07-30 US disclosed
US-20090134119-A1 FILM-FORMING MATERIAL AND METHOD OF FORMING PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2009-05-28 US disclosed
US-20090087625-A1 METHOD FOR MANUFACTURING STRUCTURE, AND STRUCTURE TOKYO OHKA KOGYO CO., LTD. (JP) 2009-04-02 US disclosed
US-20090061170-A1 ANISOTROPIC FILM AND METHOD OF MANUFACTURING ANISOTROPIC FILM TOKYO OHKA KOGYO CO., LTD. (JP) 2009-03-05 US disclosed
US-20090042129-A1 POSITIVE RESIST COMPOSITION AND METHOD FOR RESIST PATTERN FORMATION TOKYO OHKA KOGYO CO., LTD. (JP) 2009-02-12 US disclosed
US-20090029284-A1 PATTERN COATING MATERIAL AND PATTERN FORMING METHOD TOKYO OHKA KOGYO CO., LTD. (JP) 2009-01-29 US disclosed
EP-1895576-A1 PATTERN COATING MATERIAL AND PATTERN FORMING METHOD TOKYO OHKA KOGYO CO., LTD. (JP) 2008-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234316-A1 Nucleoside Aryl Phosphoramidates for the Treatment of RNA-Dependent RNA Viral Infection NSUN2, NSUN3, RNGTT CYP2C9 1330/4885FDFT1 653/4885HSD11B1 3274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.